Proceed with CT Chest Without Contrast to Evaluate for Early Small Airways Disease and Emphysema
Despite normal pulmonary function tests and chest X-ray, this symptomatic 55-year-old smoker with 15 pack-years requires CT chest without contrast as the next diagnostic step to detect subclinical smoking-related lung disease that commonly causes exertional dyspnea before spirometry becomes abnormal 1.
Why Standard Testing Misses Early Disease in Symptomatic Smokers
Your patient represents a well-documented clinical entity: the "symptomatic smoker with preserved spirometry." This is not a benign finding to dismiss. Research demonstrates that approximately half of smokers without spirometric airflow obstruction have significant respiratory symptoms, structural lung disease on imaging, and are at risk for faster lung function decline 2. The key issue is that:
- Standard spirometry (FEV1/FVC ratio) fails to detect early small airways disease that causes dyspnea in smokers 3, 2
- Chest X-rays lack sensitivity for early emphysema and small airways pathology 4
- Normal PFTs do not exclude clinically significant lung disease in this population 3, 4
The Diagnostic Algorithm
Step 1: CT Chest Without Contrast (Next Immediate Step)
The ACR Appropriateness Criteria (2025) specifically designates chest CT without contrast as "usually appropriate" for chronic dyspnea when the etiology is unclear or when COPD/small airways disease is suspected 1. This is your guideline-directed next step.
What you're looking for on CT:
- Centrilobular emphysema - can be present with normal spirometry and isolated low diffusing capacity 4
- Air trapping on expiratory images - associated with small airways disease in smokers even with normal PFTs 1
- Reduced pulmonary vascular volume - correlates with exertional dyspnea and reduced DLCO independent of emphysema extent 5
Step 2: Add Diffusing Capacity (DLCO) if Not Already Done
If your "pulmonary function tests" didn't include DLCO, order it now. Studies show that:
- Reduced DLCO is frequently the first abnormality in symptomatic smokers with preserved FEV1 5, 4
- Low DLCO correlates with structural vascular and parenchymal changes on CT that explain exertional symptoms 5
- A 1992 landmark study found emphysema on HRCT in symptomatic smokers with normal chest X-rays and isolated low DLCO 4
Step 3: Consider Advanced Spirometry Metrics
If basic spirometry is truly normal, look at FEF25-75 (forced expiratory flow at 25-75% of FVC), which measures small and medium airway obstruction:
- FEF25-75 can detect early COPD before FEV1/FVC becomes abnormal 6
- This metric allows earlier diagnosis and monitoring of treatment response 6
Common Pitfalls to Avoid
Don't dismiss symptoms because spirometry is "normal" - This is the most dangerous error. Normal FEV1/FVC does not exclude significant smoking-related lung disease 3, 2, 4.
Don't assume cardiac workup being "unremarkable" rules out all causes - While cardiac disease is excluded, pulmonary vascular disease (reduced vascular volume) can cause identical symptoms and is detected on CT, not cardiac testing 5.
Don't wait for spirometry to worsen - By the time FEV1/FVC drops below 0.70, substantial irreversible lung damage has occurred. Early detection matters 2.
What the CT Will Likely Show
Based on the evidence, this patient probably has one or more of:
- Subclinical emphysema (present in symptomatic smokers with normal PFTs) 4
- Small airways disease with air trapping (correlates with symptoms even when spirometry is normal) 3
- Reduced pulmonary vascular volume (associated with exertional dyspnea independent of emphysema) 5
If CT Shows Abnormalities
Consider inspiratory/expiratory CT protocol if initial CT is equivocal, as expiratory images specifically reveal air trapping that correlates with small airways disease 1. The ACR guidelines note this has a specific role in evaluating chronic dyspnea for small airways pathology 1.
Management Implications
If CT confirms early disease, the evidence supports that LAMA-LABA combination therapy is more effective than LAMA alone for small airways obstruction, even in early disease 6. However, diagnosis must precede treatment decisions.